These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Application of the Porto criteria for the diagnosis of paediatric inflammatory bowel disease in a paediatric reference centre]. Martín de Carpi J; Vila V; Varea V An Pediatr (Barc); 2011 Oct; 75(4):232-8. PubMed ID: 21549650 [TBL] [Abstract][Full Text] [Related]
44. [Lymphoproliferative disorders in an inflammatory bowel disease unit]. Van Domselaar M; López San Román A; Bastos Oreiro M; Garrido Gómez E Gastroenterol Hepatol; 2010 Jan; 33(1):12-6. PubMed ID: 19889478 [TBL] [Abstract][Full Text] [Related]
45. [Optimizing effect of infliximab upon inflammatory bowel disease]. Li SR; Sheng JQ; Li SJ; Zhao XJ Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(36):2568-70. PubMed ID: 20137621 [TBL] [Abstract][Full Text] [Related]
46. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Cohen RD; Stein R; Hanauer SB Am J Gastroenterol; 1999 Jun; 94(6):1587-92. PubMed ID: 10364029 [TBL] [Abstract][Full Text] [Related]
47. Cannabis use amongst patients with inflammatory bowel disease. Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981 [TBL] [Abstract][Full Text] [Related]
49. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005. Herrinton LJ; Liu L; Fireman B; Lewis JD; Allison JE; Flowers N; Hutfless S; Velayos FS; Abramson O; Altschuler A; Perry GS Gastroenterology; 2009 Aug; 137(2):502-11. PubMed ID: 19445944 [TBL] [Abstract][Full Text] [Related]
50. Colorectal carcinoma in inflammatory bowel disease: a comparison between Crohn's and ulcerative colitis. Averboukh F; Ziv Y; Kariv Y; Zmora O; Dotan I; Klausner JM; Rabau M; Tulchinsky H Colorectal Dis; 2011 Nov; 13(11):1230-5. PubMed ID: 21689324 [TBL] [Abstract][Full Text] [Related]
51. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study. Khan N; Abbas AM; Lichtenstein GR; Loftus EV; Bazzano LA Gastroenterology; 2013 Nov; 145(5):1007-1015.e3. PubMed ID: 23891975 [TBL] [Abstract][Full Text] [Related]
52. A national survey on the patterns of treatment of inflammatory bowel disease in Canada. Hilsden RJ; Verhoef MJ; Best A; Pocobelli G BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168 [TBL] [Abstract][Full Text] [Related]
55. Epidemiological aspects of inflammatory bowel disease in a north Italian population: a 4-year prospective study. Ranzi T; Bodini P; Zambelli A; Politi P; Lupinacci G; Campanini MC; Dal Lago AL; Lisciandrano D; Bianchi PA Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):657-61. PubMed ID: 8853254 [TBL] [Abstract][Full Text] [Related]
56. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study. Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308 [TBL] [Abstract][Full Text] [Related]
57. Colorectal cancer complicating inflammatory bowel disease: a comparative study of Crohn's disease vs ulcerative colitis in 34 patients. Ouaïssi M; Maggiori L; Alves A; Giger U; Sielezneff I; Valleur P; Sastre B; Panis Y Colorectal Dis; 2011 Jun; 13(6):684-8. PubMed ID: 20184639 [TBL] [Abstract][Full Text] [Related]
58. Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center. Ott C; Girlich C; Klebl F; Plentz A; Iesalnieks I; Schölmerich J; Obermeier F Digestion; 2011; 84(3):187-92. PubMed ID: 21646782 [TBL] [Abstract][Full Text] [Related]
59. Epidemiological and clinical features of Spanish patients with Crohn's disease. Spanish Epidemiological and Economic Study Group on Crohn's disease. Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1121-7. PubMed ID: 10524641 [TBL] [Abstract][Full Text] [Related]
60. A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. Riley TR; Schoen RE; Lee RG; Rakela J Am J Gastroenterol; 1997 Feb; 92(2):279-82. PubMed ID: 9040206 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]